RENAL CELL CARCINOMA STAGE IV

This adverse event was reported 113 times

These drugs are most commonly taken by patients reporting RENAL CELL CARCINOMA STAGE IV:

# Drug Count
0 SUNITINIB MALATE 26
1 PAZOPANIB HYDROCHLORIDE 19
2 SORAFENIB 16
3 METOPROLOL TARTRATE 13
4 METOPROLOL 11
5 METOPROLOL TARTRATE INJECTION 10
6 OMEPRAZOLE MAGNESIUM 10
7 ESOMEPRAZOLE MAGNESIUM 9
8 MESALAMINE 9
9 AXITINIB 8
See all common drugs associated with RENAL CELL CARCINOMA STAGE IV

RENAL CELL CARCINOMA STAGE IV is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 POTASSIUM PHOSPHATE, MONOBASIC AND SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS 1 0.0055
1 NALBUPHINE HYDROCHLORIDE 1 0.0044
2 DOCUSATE SODIUM 50MG AND SENNOSIDES 8.6MG 1 0.0011
3 SORAFENIB 16 0.0008
4 PAZOPANIB HYDROCHLORIDE 19 0.0007
5 SUNITINIB MALATE 26 0.0007
6 INFLIXIMAB-DYYB 2 0.0006
7 OMAVELOXOLONE 1 0.0006
8 VINBLASTINE SULFATE 1 0.0005
9 SULINDAC 1 0.0004
See all drugs enriched for association with RENAL CELL CARCINOMA STAGE IV